More
    Guided Solutions - Connecting Talent With Innovation/div>

    Invenio completes enrolment in AI-based lung cancer imaging trial

    California-based diagnostic imaging firm, Invenio Imaging, has announced that it has completed enrolment for a pivotal trial of its artificial intelligence (AI) driven software...

    PhotoPharmics reaches a third of enrolment goal for PD light therapy trial

    PhotoPharmics has enrolled the first 100 subjects in its clinical trial investigating a light therapy device designed for the treatment of Parkinson’s disease (PD).The...

    Fractyl Health touts positive year-long weight loss results for Revita device

    Fractyl Health has reported positive results for its hydrothermal ablation device Revita, as the company looks to battle the booming pharmaceutical weight loss therapy...

    Galvanize concludes enrolment in study of Aliya PEF system for NSCLC

    Galvanize Therapeutics has announced the completion of patient enrolment in the AFFINITY study assessing the Aliya pulsed electric field (PEF) system in treating late-stage...

    Implantica reveals positive results for IEM implant 

    Implantica has revealed positive results for its RefluxStop implant, a device designed to treat patients with a sub-type of gastro-oesophageal reflux disease.The results, published...

    Microbot Medical enrols first patient in surgical robot trial

    Microbot Medical announced the completion of the first procedure in a clinical trial using its surgical robot system. Investigators in the company’s pivotal human...

    CSA Medical completes enrolment in chronic bronchitis trial

    CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic bronchitis (CB).The double-blind, sham-controlled...

    Vectorious Medical reports positive data from study of miniature heart sensor

    Vectorious Medical Technologies today announced data supporting its V-LAP system and novel therapeutic approach for heart failure.Tel Aviv, Israel–based Vectorious develops a miniature digital...

    Genetesis enrols first subject for MICRO2 trial

    Genetesis has enrolled the first patient marking the start of its magnetocardiography as a non-invasive diagnostic strategy for suspected myocardial ischemia with the absence...

    Latest articles